GeneDx Holdings (WGS) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -86.40% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 84.25% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -424.43% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 196.25% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 126.54% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -119.00% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 122.24% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 523.25% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 1,335.09% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -31.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.36% |
| Mar 31, 2026 | -176.41% |
| Dec 31, 2025 | -66.94% |
| Sep 30, 2025 | 1,101.76% |
| Jun 30, 2025 | 7.29% |
| Mar 31, 2025 | 190.53% |
| Dec 31, 2024 | 120.67% |
| Sep 30, 2024 | 102.62% |
| Jun 30, 2024 | 51.91% |
| Mar 31, 2024 | -120.89% |
| Dec 31, 2023 | 118.36% |
| Sep 30, 2023 | 25.75% |
| Jun 30, 2023 | -239.85% |
| Mar 31, 2023 | 189.56% |
| Dec 31, 2022 | -11.07% |
| Sep 30, 2022 | -121.96% |
| Jun 30, 2022 | 47.48% |
| Mar 31, 2022 | -72.93% |
| Dec 31, 2021 | -5,645.63% |
| Sep 30, 2021 | 37,167.97% |